Fewer vaccine doses still support pneumococcal immunity, shows clinical trial
A unique study published this month outlines new ways to protect more of the world's population from vaccine-preventable diseases.
Apr 26, 2023
0
29
A unique study published this month outlines new ways to protect more of the world's population from vaccine-preventable diseases.
Apr 26, 2023
0
29
A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials.
Apr 20, 2023
0
46
A low-cost, protein-based COVID-19 vaccine tested in rhesus monkeys by Stanford Medicine researchers and colleagues offered immunity against known variants for at least one year. Researchers hope the vaccine, which can remain ...
Apr 18, 2023
0
33
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune ...
Mar 6, 2023
0
98
A team of medical researchers from Amyris, Inc. and the Access to Advanced Health Institute has developed a new way to synthesize squalene, a natural terpene used to boost the effectiveness of several vaccines. In their paper ...
The COVID-19 Prevention Network (CoVPN), headquartered at Fred Hutchinson Cancer Center in Seattle, was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the ...
Jan 24, 2023
0
10
COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future "variants of concern," say scientists at the University of Cambridge and Medical ...
Dec 14, 2022
0
52
There's even more reason to think a vaccine developed against smallpox can help the body fight against mpox (monkeypox virus disease) as well, according to researchers at La Jolla Institute for Immunology (LJI). Their new ...
Dec 7, 2022
0
162
Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for ...
Nov 18, 2022
0
57
COVID-19 vaccines and drugs were developed at "warp speed" and now experts are concerned about the US Food and Drug Administration's (FDA) inadequate surveillance of clinical trial sites, reports an investigation published ...
Nov 16, 2022
0
84